Platform Technology Partners Acquires 238 Shares of The Clorox Company (NYSE:CLX)

12 Nov 2024, 08:52 by Jessica Moore · The Cerbat Gem

Platform Technology Partners grew its holdings in shares of The Clorox Company (NYSE:CLX – Free Report) by 3.4% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 7,230 shares of the company’s stock after purchasing an additional 238 shares during the quarter. Platform Technology Partners’ holdings in Clorox were worth $1,178,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also modified their holdings of the company. Innealta Capital LLC acquired a new stake in shares of Clorox in the second quarter worth about $30,000. Trifecta Capital Advisors LLC lifted its holdings in Clorox by 139.8% in the 2nd quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after purchasing an additional 130 shares during the last quarter. First Foundation Advisors bought a new stake in Clorox during the first quarter worth approximately $31,000. Family Firm Inc. acquired a new position in Clorox during the second quarter valued at approximately $31,000. Finally, Quarry LP raised its position in shares of Clorox by 99.1% in the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares during the period. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Transactions at Clorox

In related news, EVP Angela C. Hilt sold 1,733 shares of the business’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at $2,229,719.92. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.57% of the stock is currently owned by insiders.

Clorox Stock Down 0.1 %

CLX opened at $165.05 on Tuesday. The company has a market capitalization of $20.43 billion, a P/E ratio of 57.51, a P/E/G ratio of 3.05 and a beta of 0.41. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The firm’s fifty day moving average price is $162.28 and its two-hundred day moving average price is $146.95. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $169.09.

Clorox (NYSE:CLX – Get Free Report) last issued its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same period in the previous year, the business earned $0.49 EPS. The firm’s revenue was up 27.0% on a year-over-year basis. On average, analysts anticipate that The Clorox Company will post 6.85 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were paid a $1.22 dividend. The ex-dividend date was Wednesday, October 23rd. This represents a $4.88 annualized dividend and a dividend yield of 2.96%. Clorox’s dividend payout ratio is currently 170.04%.

Analyst Upgrades and Downgrades

CLX has been the subject of several recent analyst reports. Barclays upped their price objective on shares of Clorox from $137.00 to $139.00 and gave the stock an “underweight” rating in a report on Friday, November 1st. Evercore ISI lowered their price target on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research report on Monday, October 14th. JPMorgan Chase & Co. boosted their price objective on Clorox from $148.00 to $174.00 and gave the stock a “neutral” rating in a research report on Friday, October 11th. BNP Paribas upgraded Clorox to a “strong sell” rating in a research note on Friday, September 6th. Finally, Citigroup lifted their price target on Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research report on Friday, September 6th. Five research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $155.00.

View Our Latest Stock Report on Clorox

Clorox Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.